Shopping Cart 0
Cart Subtotal
AED 0

Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) - Forecast Till 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 16332

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 22938

Details

Introduction

The needle-free injection system is a novel technique used to introduce medicines to patients without piercing the skin with conventional needles. This technology offers the benefit of reducing patient concern about the use of needles. These injections are very effective for a wide range of drugs and results in less pain and hence are strongly preferred by patients. Additional benefits of these needle-free injections include fast results as compared to conventional needles and no issue of needle disposal. This technique could be used to administer vaccines and medications in the pork industry. The rising prevalence of various chronic diseases is propelling the need for needle-free injections. Increase in investments in the pharmaceutical sector and convenient use of these medical devices in home care are projected to drive market growth over the forecast period.

However, the high cost of these devices, strict regulatory bodies, and stringent regulatory policies are expected to restrain market growth during the forecast period.

The global needle-free injection market has been segmented, by product, technology, usability, type of medication, site of delivery, application, and end user.

Based on product type, the global needle-free injection market has been categorized as fillable needle-free injectors and prefilled needle-free injectors.

On the basis of technology, the global needle-free injection market is further sub-segmented into jet-based, spring-based, and laser-powered.

By usability, the global needle-free injection market is further sub-segmented into reusable needle-free injectors and disposable needle-free injectors.

The global needle-free injection market by type of medication is further sub-segmented into liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors.

On the basis of site of delivery, the global needle-free injection market is further sub-segmented into intradermal injectors, intramuscular injectors, and subcutaneous injectors.

By application, the global needle-free injection market is further sub-segmented into vaccination, insulin delivery, and oncology.

On the basis of end user, the market has been classified as hospitals and clinics, ambulatory surgical centers, and home care settings.

The global needle-free injection market was valued at USD 10,377.7 million in 2017 and is expected to register a CAGR of 15.28 % during the forecast period from 2017 to 2023.

Key Players

Some of the key players in the global needle-free injection market are Antares Pharma Inc., Endo Pharmaceuticals Inc., PharmaJet Inc., Inovio Pharmaceuticals Inc., Medical International Technology Inc., INJEX Pharma GmBH, National Medical Products Inc, European Pharma Group, PenJet Corporation, Valeritas Holdings Inc, Crossject, Mika Medical Co., and D'Antonio Consultants International Inc.

Objectives of the Study

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global needle-free injection market

To provide insights into factors influencing and affecting market growth

To provide historical and forecast revenue of market segments and sub-segments with respect to countries

To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global needle-free injection market

To provide a detailed analysis of the value chain and supply chain of the global needle-free injection market

Target Audience

Government Research Institutes

Research and Development (R&D) Companies

Medical Devices Companies

Academic Institutes and Universities

Key Findings

The global needle-free injection market is expected to reach USD 25,057.4 million by 2023 at a CAGR of 15.28 % from 2017 to 2023

Based on technology, the jet-based needle-free injectors segment holds the largest market share and is expected to reach USD 10,391.3 million by 2023 at a CAGR of 15.90% from 2017 to 2023

The market in the Americas is expected to account for the largest share of the global needle-free injection market and is projected to reach USD 8,750.7 million by 2023

The needle-free injection market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 15.74 % from 2017 to 2023

Regional Analysis

Americas

o North America

US

Canada

o Latin America

Europe

o Western Europe

Germany

France

UK

Italy

Spain

Rest of Western Europe

o Eastern Europe

Asia-Pacific

o Japan

o China

o India

o Australia

o South Korea

o Rest of Asia-Pacific

Middle East & Africa

o Middle East

o Africa

READ MORE

Table Of Content

Scope

Table of Contents:

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Assumptions & Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing prevalence of chronic conditions such as diabetes is estimated to increase the demand

for needle-free injectors

4.2.2 Capacity of needle-free injectors to support homecare

4.2.3 Growing biopharmaceuticals industry

4.2.4 Increasing investments in the market

4.2.5 Drivers Impact Analysis

4.3 Restraints

4.3.1 Risks of Cross Contamination

4.3.2 High Cost

4.3.3 Restraints Impact Analysis

4.4 Opportunity

4.4.1 Increasing campaigns of vaccination in developing economies of the Asia Pacific region

4.5 Macroeconomic Indicators

5 Market Factor Analysis

5.1 Value Chain Analysis

5.1.1 R&D & Designing

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-Sales Review

?

5.2 Porter's Five Forces Model

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Buyers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitutes

5.2.5 Intensity of Rivalry

5.3 Investment Opportunities

5.4 Pricing Analysis

6 Global Needle Free Injection Market, By Product

6.1 Introduction

6.2 Fillable Needle-Free Injectors

6.3 Prefilled Needle-Free Injectors

7 Global Needle Free Injection Market, By Technology

7.1 Introduction

7.2 Jet-Based

7.3 Spring-Based

7.4 Laser-Powered

8 Global Needle Free Injection Market, By Usability

8.1 Introduction

8.2 Reusable Needle-Free Injectors

8.3 Disposable Needle-Free Injectors

9 Global Needle Free Injection Market, By Type of Medication

9.1 Introduction

9.2 Liquid-Based Needle Free Injectors

9.3 Powder-Based Needle Free Injectors

9.4 Projectile/Depot-Based Needle Free Injectors

10 Global Needle Free Injection Market, By Site of Delivery

10.1 Introduction

10.2 Intra dermal injectors

10.3 Intramuscular injectors

10.4 Subcutaneous injectors

11 Global Needle Free Injection Market, By Application

11.1 Introduction

11.2 Vaccination

11.3 Insulin Delivery

11.4 Oncology

12 Global Needle Free Injection Market, By End Users

12.1 Introduction

12.2 Hospitals and Clinics

12.3 Ambulatory Surgical Centres

12.4 Homecare Settings

13 Global Needle Free Injection Market, By Region

13.1 Introduction

13.2 Americas

13.2.1 North America

13.2.1.1 U.S

13.2.1.2 Canada

13.2.2 South America

13.3 Europe

13.3.1 Western Europe

13.3.1.1 Germany

13.3.1.2 France

13.3.1.3 U.K

13.3.1.4 Italy

13.3.1.5 Spain

13.3.1.6 Rest of Western Europe

13.3.2 Eastern Europe

13.4 Asia Pacific

13.4.1 China

13.4.2 India

13.4.3 Japan

13.4.4 South Korea

13.4.5 Rest of Asia Pacific

13.5 Middle East & Africa

13.6 The Middle East

13.6.1 Africa

14 Competitive Landscape

14.1 Introduction

14.2 Recent Developments, 2014-2018

15 Company Profiles

15.1 Antares Pharma Inc.

15.1.1 Company Overview

15.1.2 Financial Overview

15.1.3 Products Offering

15.1.4 Key Developments

15.1.5 SWOT Analysis

15.1.6 Key Strategy

15.2 Endo Pharmaceuticals Inc.

15.2.1 Company Overview

15.2.2 Financial Overview

15.2.3 Products Offering

15.2.4 Key Developments

15.2.5 SWOT Analysis

15.2.6 Key Strategy

15.3 PharmaJet, Inc

15.3.1 Company Overview

15.3.2 Financial Overview

15.3.3 Products Offering

15.3.4 Key Developments

15.3.5 SWOT Analysis

15.3.6 Key Strategy

15.4 Inovio Pharmaceuticals Inc.

15.4.1 Company Overview

15.4.2 Financial Overview

15.4.3 Products Offering

15.4.4 Key Developments

15.4.5 SWOT Analysis

15.4.6 Key Strategy

15.5 Medical International Technology, Inc.

15.5.1 Company Overview

15.5.2 Financial Overview

15.5.3 Products Offering

15.5.4 Key Developments

15.5.5 SWOT Analysis

15.5.6 Key Strategy

15.6 INJEX Pharma GmBH

15.6.1 Company Overview

15.6.2 Financial Overview

15.6.3 Products Offering

15.6.4 Key Developments

15.6.5 SWOT Analysis

15.6.6 Key Strategy

15.7 National Medical Products Inc.

15.7.1 Company Overview

15.7.2 Financial Overview

15.7.3 Products Offering

15.7.4 Key Developments

15.7.5 SWOT Analysis

15.7.6 Key Strategy

15.8 European Pharma Group

15.8.1 Company Overview

15.8.2 Financial Overview

15.8.3 Products Offering

15.8.4 Key Developments

15.8.5 SWOT Analysis

15.8.6 Key Strategy

15.9 PenJet Corporation

15.9.1 Company Overview

15.9.2 Financial Overview

15.9.3 Products Offering

15.9.4 SWOT Analysis

15.9.5 Key Strategy

15.1 Valeritas Holdings, Inc.

15.10.1 Company Overview

15.10.2 Financial Overview

15.10.3 Products Offering

15.10.4 Key Developments

15.10.5 SWOT Analysis

15.10.6 Key Strategy

15.11 CROSSJECT

15.11.1 Company Overview

15.11.2 Financial Overview

15.11.3 Products Offering

15.11.4 Key Developments

15.11.5 SWOT Analysis

15.11.6 Key Strategy

15.12 MIKA MEDICAL CO.

15.12.1 Company Overview

15.12.2 Financial Overview

15.12.3 Products Offering

15.12.4 Key Developments

15.12.5 SWOT Analysis

15.12.6 Key Strategy

15.13 D'Antonio Consultants International, Inc.

15.13.1 Company Overview

15.13.2 Financial Overview

15.13.3 Products Offering

15.13.4 Key Developments

15.13.5 SWOT Analysis

15.13.6 Key Strategy

16 Appendix

16.1 Discussion Blue Print


List Of Figure

List of Figures:

FIGURE 1 MARKET STRUCTURE

FIGURE 2 RESEARCH PROCESS

FIGURE 3 DROC ANALYSIS OF GLOBAL NEEDLE FREE INJECTION MARKET

FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL NEEDLE FREE INJECTION MARKET

FIGURE 5 RESTRAINTS IMPACT ANALYSIS: NEEDLE FREE INJECTION MARKET

FIGURE 6 VALUE CHAIN: GLOBAL NEEDLE-FREE INJECTION MARKET

FIGURE 7 PORTER'S FIVE FORCES MODEL: GLOBAL NEEDLE-FREE INJECTION MARKET

FIGURE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2017 & 2023 (USD MILLION)

FIGURE 10 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2017 & 2023 (USD MILLION)

FIGURE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2017 & 2023 (USD MILLION)

FIGURE 12 GLOBAL NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2017 & 2023 (USD MILLION)

FIGURE 13 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 14 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2017 & 2023 (USD MILLION)

FIGURE 15 GLOBAL NEEDLE FREE INJECTION MARKET SHARE BY, REGION 2017 (%)

FIGURE 16 AMERICAS NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2017 (%)

FIGURE 17 EUROPE NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2017 (%)

FIGURE 18 ASIA PACIFIC NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2017 (%)

FIGURE 19 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2017 (%)

FIGURE 20 GLOBAL NEEDLE FREE INJECTION MARKET, COMPETITIVE LANDSCAPE, 2017 (%)


List Of Table

List of Tables:

TABLE 1 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 2 GLOBAL NEEDLE FREE INJECTION MARKET FOR FILLABLE NEEDLE-FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 3 GLOBAL NEEDLE FREE INJECTION MARKET FOR PREFILLED NEEDLE-FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 4 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 5 GLOBAL NEEDLE FREE INJECTION MARKET FOR JET-BASED 2015-2023 (USD MILLION)

TABLE 6 GLOBAL NEEDLE FREE INJECTION MARKET FOR SPRING-BASED 2015-2023 (USD MILLION)

TABLE 7 GLOBAL NEEDLE FREE INJECTION MARKET FOR LASER-POWERED 2015-2023 (USD MILLION)

TABLE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 9 GLOBAL NEEDLE FREE INJECTION MARKET FOR REUSABLE NEEDLE-FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 10 GLOBAL NEEDLE FREE INJECTION MARKET FOR DISPOSABLE NEEDLE-FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 12 GLOBAL NEEDLE FREE INJECTION MARKET FOR LIQUID-BASED NEEDLE FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 13 GLOBAL NEEDLE FREE INJECTION MARKET FOR POWDER-BASED NEEDLE FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 14 GLOBAL NEEDLE FREE INJECTION MARKET FOR PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS

2015-2023 (USD MILLION)

TABLE 15 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 16 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRA DERMAL INJECTORS 2015-2023 (USD MILLION)

TABLE 17 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRAMUSCULAR INJECTORS 2015-2023 (USD MILLION)

TABLE 18 GLOBAL NEEDLE FREE INJECTION MARKET FOR SUBCUTANEOUS INJECTORS 2015-2023 (USD MILLION)

TABLE 19 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 20 GLOBAL NEEDLE FREE INJECTION MARKET FOR VACCINATION 2015-2023 (USD MILLION)

TABLE 21 GLOBAL NEEDLE FREE INJECTION MARKET FOR INSULIN DELIVERY 2015-2023 (USD MILLION)

TABLE 22 GLOBAL NEEDLE FREE INJECTION MARKET FOR ONCOLOGY 2015-2023 (USD MILLION)

TABLE 23 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 24 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOSPITALS AND CLINICS 2015-2023 (USD MILLION)

TABLE 25 GLOBAL NEEDLE FREE INJECTION MARKET FOR AMBULATORY SURGICAL CENTRES 2015-2023 (USD MILLION)

TABLE 26 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOMECARE SETTINGS 2015-2023 (USD MILLION)

TABLE 27 GLOBAL NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 28 AMERICAS NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 29 AMERICAS NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 30 AMERICAS NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 31 AMERICAS NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 32 AMERICAS NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 33 AMERICAS NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 34 AMERICAS NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 35 AMERICAS NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 36 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 37 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 38 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 39 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 40 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 41 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 42 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 43 U.S NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 44 U.S NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 45 U.S NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 46 U.S NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 47 U.S NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 48 U.S NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 49 U.S NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 50 CANADA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 51 CANADA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 52 CANADA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 53 CANADA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 54 CANADA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 55 CANADA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 56 CANADA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 57 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 58 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 59 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 60 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 61 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 62 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 63 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 64 EUROPE NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 65 EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 66 EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 67 EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 68 EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 69 EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 70 EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 71 EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 72 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 73 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 74 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 75 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 76 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 77 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 78 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 79 GERMANY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 80 GERMANY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 81 GERMANY NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 82 GERMANY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 83 GERMANY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 84 GERMANY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 85 GERMANY NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 86 FRANCE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 87 FRANCE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 88 FRANCE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 89 FRANCE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 90 FRANCE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 91 FRANCE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 92 FRANCE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 93 U.K NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 94 U.K NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 95 U.K NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 96 U.K NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 97 U.K NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 98 U.K NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 99 U.K NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 100 ITALY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 101 ITALY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 102 ITALY NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 103 ITALY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 104 ITALY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 105 ITALY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 106 ITALY NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 107 SPAIN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 108 SPAIN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 109 SPAIN NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 110 SPAIN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 111 SPAIN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 112 SPAIN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 113 SPAIN NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 114 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 115 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 116 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 117 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 118 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 119 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 120 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 121 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 122 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 123 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 124 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 125 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 126 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 127 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 128 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 129 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 130 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 131 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 132 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 133 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 134 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 135 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 136 CHINA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 137 CHINA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 138 CHINA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 139 CHINA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 140 CHINA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 141 CHINA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 142 CHINA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 143 INDIA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 144 INDIA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 145 INDIA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 146 INDIA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 147 INDIA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 148 INDIA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 149 INDIA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 150 JAPAN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 151 JAPAN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 152 APAN NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 153 JAPAN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 154 JAPAN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 155 JAPAN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 156 JAPAN NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 157 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 158 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 159 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 160 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 161 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 162 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 163 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 164 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 165 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 166 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 167 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 168 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 169 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 170 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 171 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 172 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 173 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 174 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 175 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 176 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 177 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 178 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 179 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 180 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 181 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 182 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 183 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 184 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 185 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 186 AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 187 AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 188 AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 189 AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 190 AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 191 AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 192 AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Antares Pharma Inc

Endo Pharmaceuticals Inc

PharmaJet, Inc

Inovio Pharmaceuticals Inc

Medical International Technology, Inc

INJEX Pharma GmBH

National Medical Products Inc

European Pharma Group

PenJet Corporation

Valeritas Holdings, Inc

CROSSJECT

MIKA MEDICAL CO

D'Antonio Consultants International, Inc

Company Profile

Company Profile Title

Introduction

The needle-free injection system is a novel technique used to introduce medicines to patients without piercing the skin with conventional needles. This technology offers the benefit of reducing patient concern about the use of needles. These injections are very effective for a wide range of drugs and results in less pain and hence are strongly preferred by patients. Additional benefits of these needle-free injections include fast results as compared to conventional needles and no issue of needle disposal. This technique could be used to administer vaccines and medications in the pork industry. The rising prevalence of various chronic diseases is propelling the need for needle-free injections. Increase in investments in the pharmaceutical sector and convenient use of these medical devices in home care are projected to drive market growth over the forecast period.

However, the high cost of these devices, strict regulatory bodies, and stringent regulatory policies are expected to restrain market growth during the forecast period.

The global needle-free injection market has been segmented, by product, technology, usability, type of medication, site of delivery, application, and end user.

Based on product type, the global needle-free injection market has been categorized as fillable needle-free injectors and prefilled needle-free injectors.

On the basis of technology, the global needle-free injection market is further sub-segmented into jet-based, spring-based, and laser-powered.

By usability, the global needle-free injection market is further sub-segmented into reusable needle-free injectors and disposable needle-free injectors.

The global needle-free injection market by type of medication is further sub-segmented into liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors.

On the basis of site of delivery, the global needle-free injection market is further sub-segmented into intradermal injectors, intramuscular injectors, and subcutaneous injectors.

By application, the global needle-free injection market is further sub-segmented into vaccination, insulin delivery, and oncology.

On the basis of end user, the market has been classified as hospitals and clinics, ambulatory surgical centers, and home care settings.

The global needle-free injection market was valued at USD 10,377.7 million in 2017 and is expected to register a CAGR of 15.28 % during the forecast period from 2017 to 2023.

Key Players

Some of the key players in the global needle-free injection market are Antares Pharma Inc., Endo Pharmaceuticals Inc., PharmaJet Inc., Inovio Pharmaceuticals Inc., Medical International Technology Inc., INJEX Pharma GmBH, National Medical Products Inc, European Pharma Group, PenJet Corporation, Valeritas Holdings Inc, Crossject, Mika Medical Co., and D'Antonio Consultants International Inc.

Objectives of the Study

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global needle-free injection market

To provide insights into factors influencing and affecting market growth

To provide historical and forecast revenue of market segments and sub-segments with respect to countries

To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global needle-free injection market

To provide a detailed analysis of the value chain and supply chain of the global needle-free injection market

Target Audience

Government Research Institutes

Research and Development (R&D) Companies

Medical Devices Companies

Academic Institutes and Universities

Key Findings

The global needle-free injection market is expected to reach USD 25,057.4 million by 2023 at a CAGR of 15.28 % from 2017 to 2023

Based on technology, the jet-based needle-free injectors segment holds the largest market share and is expected to reach USD 10,391.3 million by 2023 at a CAGR of 15.90% from 2017 to 2023

The market in the Americas is expected to account for the largest share of the global needle-free injection market and is projected to reach USD 8,750.7 million by 2023

The needle-free injection market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 15.74 % from 2017 to 2023

Regional Analysis

Americas

o North America

US

Canada

o Latin America

Europe

o Western Europe

Germany

France

UK

Italy

Spain

Rest of Western Europe

o Eastern Europe

Asia-Pacific

o Japan

o China

o India

o Australia

o South Korea

o Rest of Asia-Pacific

Middle East & Africa

o Middle East

o Africa

READ MORE

Scope

Table of Contents:

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Assumptions & Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing prevalence of chronic conditions such as diabetes is estimated to increase the demand

for needle-free injectors

4.2.2 Capacity of needle-free injectors to support homecare

4.2.3 Growing biopharmaceuticals industry

4.2.4 Increasing investments in the market

4.2.5 Drivers Impact Analysis

4.3 Restraints

4.3.1 Risks of Cross Contamination

4.3.2 High Cost

4.3.3 Restraints Impact Analysis

4.4 Opportunity

4.4.1 Increasing campaigns of vaccination in developing economies of the Asia Pacific region

4.5 Macroeconomic Indicators

5 Market Factor Analysis

5.1 Value Chain Analysis

5.1.1 R&D & Designing

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-Sales Review

?

5.2 Porter's Five Forces Model

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Buyers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitutes

5.2.5 Intensity of Rivalry

5.3 Investment Opportunities

5.4 Pricing Analysis

6 Global Needle Free Injection Market, By Product

6.1 Introduction

6.2 Fillable Needle-Free Injectors

6.3 Prefilled Needle-Free Injectors

7 Global Needle Free Injection Market, By Technology

7.1 Introduction

7.2 Jet-Based

7.3 Spring-Based

7.4 Laser-Powered

8 Global Needle Free Injection Market, By Usability

8.1 Introduction

8.2 Reusable Needle-Free Injectors

8.3 Disposable Needle-Free Injectors

9 Global Needle Free Injection Market, By Type of Medication

9.1 Introduction

9.2 Liquid-Based Needle Free Injectors

9.3 Powder-Based Needle Free Injectors

9.4 Projectile/Depot-Based Needle Free Injectors

10 Global Needle Free Injection Market, By Site of Delivery

10.1 Introduction

10.2 Intra dermal injectors

10.3 Intramuscular injectors

10.4 Subcutaneous injectors

11 Global Needle Free Injection Market, By Application

11.1 Introduction

11.2 Vaccination

11.3 Insulin Delivery

11.4 Oncology

12 Global Needle Free Injection Market, By End Users

12.1 Introduction

12.2 Hospitals and Clinics

12.3 Ambulatory Surgical Centres

12.4 Homecare Settings

13 Global Needle Free Injection Market, By Region

13.1 Introduction

13.2 Americas

13.2.1 North America

13.2.1.1 U.S

13.2.1.2 Canada

13.2.2 South America

13.3 Europe

13.3.1 Western Europe

13.3.1.1 Germany

13.3.1.2 France

13.3.1.3 U.K

13.3.1.4 Italy

13.3.1.5 Spain

13.3.1.6 Rest of Western Europe

13.3.2 Eastern Europe

13.4 Asia Pacific

13.4.1 China

13.4.2 India

13.4.3 Japan

13.4.4 South Korea

13.4.5 Rest of Asia Pacific

13.5 Middle East & Africa

13.6 The Middle East

13.6.1 Africa

14 Competitive Landscape

14.1 Introduction

14.2 Recent Developments, 2014-2018

15 Company Profiles

15.1 Antares Pharma Inc.

15.1.1 Company Overview

15.1.2 Financial Overview

15.1.3 Products Offering

15.1.4 Key Developments

15.1.5 SWOT Analysis

15.1.6 Key Strategy

15.2 Endo Pharmaceuticals Inc.

15.2.1 Company Overview

15.2.2 Financial Overview

15.2.3 Products Offering

15.2.4 Key Developments

15.2.5 SWOT Analysis

15.2.6 Key Strategy

15.3 PharmaJet, Inc

15.3.1 Company Overview

15.3.2 Financial Overview

15.3.3 Products Offering

15.3.4 Key Developments

15.3.5 SWOT Analysis

15.3.6 Key Strategy

15.4 Inovio Pharmaceuticals Inc.

15.4.1 Company Overview

15.4.2 Financial Overview

15.4.3 Products Offering

15.4.4 Key Developments

15.4.5 SWOT Analysis

15.4.6 Key Strategy

15.5 Medical International Technology, Inc.

15.5.1 Company Overview

15.5.2 Financial Overview

15.5.3 Products Offering

15.5.4 Key Developments

15.5.5 SWOT Analysis

15.5.6 Key Strategy

15.6 INJEX Pharma GmBH

15.6.1 Company Overview

15.6.2 Financial Overview

15.6.3 Products Offering

15.6.4 Key Developments

15.6.5 SWOT Analysis

15.6.6 Key Strategy

15.7 National Medical Products Inc.

15.7.1 Company Overview

15.7.2 Financial Overview

15.7.3 Products Offering

15.7.4 Key Developments

15.7.5 SWOT Analysis

15.7.6 Key Strategy

15.8 European Pharma Group

15.8.1 Company Overview

15.8.2 Financial Overview

15.8.3 Products Offering

15.8.4 Key Developments

15.8.5 SWOT Analysis

15.8.6 Key Strategy

15.9 PenJet Corporation

15.9.1 Company Overview

15.9.2 Financial Overview

15.9.3 Products Offering

15.9.4 SWOT Analysis

15.9.5 Key Strategy

15.1 Valeritas Holdings, Inc.

15.10.1 Company Overview

15.10.2 Financial Overview

15.10.3 Products Offering

15.10.4 Key Developments

15.10.5 SWOT Analysis

15.10.6 Key Strategy

15.11 CROSSJECT

15.11.1 Company Overview

15.11.2 Financial Overview

15.11.3 Products Offering

15.11.4 Key Developments

15.11.5 SWOT Analysis

15.11.6 Key Strategy

15.12 MIKA MEDICAL CO.

15.12.1 Company Overview

15.12.2 Financial Overview

15.12.3 Products Offering

15.12.4 Key Developments

15.12.5 SWOT Analysis

15.12.6 Key Strategy

15.13 D'Antonio Consultants International, Inc.

15.13.1 Company Overview

15.13.2 Financial Overview

15.13.3 Products Offering

15.13.4 Key Developments

15.13.5 SWOT Analysis

15.13.6 Key Strategy

16 Appendix

16.1 Discussion Blue Print


List Of Figure

List of Figures:

FIGURE 1 MARKET STRUCTURE

FIGURE 2 RESEARCH PROCESS

FIGURE 3 DROC ANALYSIS OF GLOBAL NEEDLE FREE INJECTION MARKET

FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL NEEDLE FREE INJECTION MARKET

FIGURE 5 RESTRAINTS IMPACT ANALYSIS: NEEDLE FREE INJECTION MARKET

FIGURE 6 VALUE CHAIN: GLOBAL NEEDLE-FREE INJECTION MARKET

FIGURE 7 PORTER'S FIVE FORCES MODEL: GLOBAL NEEDLE-FREE INJECTION MARKET

FIGURE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2017 & 2023 (USD MILLION)

FIGURE 10 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2017 & 2023 (USD MILLION)

FIGURE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2017 & 2023 (USD MILLION)

FIGURE 12 GLOBAL NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2017 & 2023 (USD MILLION)

FIGURE 13 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 14 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2017 & 2023 (USD MILLION)

FIGURE 15 GLOBAL NEEDLE FREE INJECTION MARKET SHARE BY, REGION 2017 (%)

FIGURE 16 AMERICAS NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2017 (%)

FIGURE 17 EUROPE NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2017 (%)

FIGURE 18 ASIA PACIFIC NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2017 (%)

FIGURE 19 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2017 (%)

FIGURE 20 GLOBAL NEEDLE FREE INJECTION MARKET, COMPETITIVE LANDSCAPE, 2017 (%)


List Of Table

List of Tables:

TABLE 1 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 2 GLOBAL NEEDLE FREE INJECTION MARKET FOR FILLABLE NEEDLE-FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 3 GLOBAL NEEDLE FREE INJECTION MARKET FOR PREFILLED NEEDLE-FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 4 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 5 GLOBAL NEEDLE FREE INJECTION MARKET FOR JET-BASED 2015-2023 (USD MILLION)

TABLE 6 GLOBAL NEEDLE FREE INJECTION MARKET FOR SPRING-BASED 2015-2023 (USD MILLION)

TABLE 7 GLOBAL NEEDLE FREE INJECTION MARKET FOR LASER-POWERED 2015-2023 (USD MILLION)

TABLE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 9 GLOBAL NEEDLE FREE INJECTION MARKET FOR REUSABLE NEEDLE-FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 10 GLOBAL NEEDLE FREE INJECTION MARKET FOR DISPOSABLE NEEDLE-FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 12 GLOBAL NEEDLE FREE INJECTION MARKET FOR LIQUID-BASED NEEDLE FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 13 GLOBAL NEEDLE FREE INJECTION MARKET FOR POWDER-BASED NEEDLE FREE INJECTORS 2015-2023 (USD MILLION)

TABLE 14 GLOBAL NEEDLE FREE INJECTION MARKET FOR PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS

2015-2023 (USD MILLION)

TABLE 15 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 16 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRA DERMAL INJECTORS 2015-2023 (USD MILLION)

TABLE 17 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRAMUSCULAR INJECTORS 2015-2023 (USD MILLION)

TABLE 18 GLOBAL NEEDLE FREE INJECTION MARKET FOR SUBCUTANEOUS INJECTORS 2015-2023 (USD MILLION)

TABLE 19 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 20 GLOBAL NEEDLE FREE INJECTION MARKET FOR VACCINATION 2015-2023 (USD MILLION)

TABLE 21 GLOBAL NEEDLE FREE INJECTION MARKET FOR INSULIN DELIVERY 2015-2023 (USD MILLION)

TABLE 22 GLOBAL NEEDLE FREE INJECTION MARKET FOR ONCOLOGY 2015-2023 (USD MILLION)

TABLE 23 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 24 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOSPITALS AND CLINICS 2015-2023 (USD MILLION)

TABLE 25 GLOBAL NEEDLE FREE INJECTION MARKET FOR AMBULATORY SURGICAL CENTRES 2015-2023 (USD MILLION)

TABLE 26 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOMECARE SETTINGS 2015-2023 (USD MILLION)

TABLE 27 GLOBAL NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 28 AMERICAS NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 29 AMERICAS NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 30 AMERICAS NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 31 AMERICAS NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 32 AMERICAS NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 33 AMERICAS NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 34 AMERICAS NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 35 AMERICAS NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 36 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 37 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 38 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 39 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 40 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 41 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 42 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 43 U.S NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 44 U.S NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 45 U.S NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 46 U.S NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 47 U.S NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 48 U.S NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 49 U.S NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 50 CANADA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 51 CANADA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 52 CANADA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 53 CANADA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 54 CANADA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 55 CANADA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 56 CANADA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 57 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 58 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 59 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 60 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 61 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 62 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 63 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 64 EUROPE NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 65 EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 66 EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 67 EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 68 EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 69 EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 70 EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 71 EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 72 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 73 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 74 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 75 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 76 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 77 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 78 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 79 GERMANY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 80 GERMANY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 81 GERMANY NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 82 GERMANY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 83 GERMANY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 84 GERMANY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 85 GERMANY NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 86 FRANCE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 87 FRANCE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 88 FRANCE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 89 FRANCE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 90 FRANCE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 91 FRANCE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 92 FRANCE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 93 U.K NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 94 U.K NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 95 U.K NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 96 U.K NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 97 U.K NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 98 U.K NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 99 U.K NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 100 ITALY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 101 ITALY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 102 ITALY NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 103 ITALY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 104 ITALY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 105 ITALY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 106 ITALY NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 107 SPAIN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 108 SPAIN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 109 SPAIN NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 110 SPAIN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 111 SPAIN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 112 SPAIN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 113 SPAIN NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 114 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 115 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 116 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 117 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 118 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 119 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 120 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 121 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 122 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 123 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 124 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 125 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 126 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 127 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 128 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 129 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 130 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 131 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 132 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 133 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 134 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 135 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 136 CHINA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 137 CHINA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 138 CHINA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 139 CHINA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 140 CHINA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 141 CHINA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 142 CHINA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 143 INDIA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 144 INDIA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 145 INDIA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 146 INDIA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 147 INDIA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 148 INDIA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 149 INDIA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 150 JAPAN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 151 JAPAN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 152 APAN NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 153 JAPAN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 154 JAPAN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 155 JAPAN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 156 JAPAN NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 157 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 158 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 159 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 160 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 161 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 162 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 163 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 164 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 165 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 166 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 167 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 168 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 169 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 170 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 171 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, REGION 2015-2023 (USD MILLION)

TABLE 172 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 173 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 174 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 175 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 176 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 177 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 178 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 179 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 180 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 181 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 182 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 183 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 184 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 185 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

TABLE 186 AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2015-2023 (USD MILLION)

TABLE 187 AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 188 AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2015-2023 (USD MILLION)

TABLE 189 AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2015-2023 (USD MILLION)

TABLE 190 AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2015-2023 (USD MILLION)

TABLE 191 AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2015-2023 (USD MILLION)

TABLE 192 AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2015-2023 (USD MILLION)

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Antares Pharma Inc

Endo Pharmaceuticals Inc

PharmaJet, Inc

Inovio Pharmaceuticals Inc

Medical International Technology, Inc

INJEX Pharma GmBH

National Medical Products Inc

European Pharma Group

PenJet Corporation

Valeritas Holdings, Inc

CROSSJECT

MIKA MEDICAL CO

D'Antonio Consultants International, Inc